OGIVRI
OGIVRI
Approved
DIN Number
02474425
Drug Class
Human
Market Date
Jun 6, 2019
Company
HC
Biosimilar Collaborations Ireland Ltd.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02474425
AIG Number0154252002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L01FD01 TRASTUZUMAB
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
TRASTUZUMABActive
Strength: 150 MG / VIAL
Monograph: TRASTUZUMAB